drugset / Trial / NCT07032324
A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )
Phase 1
Not yet recruiting
27 enrolled
Qian Wenbin
Second Affiliated Hospital, School of Medicine, Zhejiang University · collab
NaSingle-groupOpen-labelTreatment
Summary
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma.
Timeline
- Start
- 2025-07-08
- Primary completion
- 2025-12-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT1190B | Cell therapy | — | — |